Corewell Health’s Post

Revolutionizing wound care, the TopiVac Medium Clinic V4 is here with its unique hybrid treatment technology! Offering an innovative approach that our competitors cannot provide, this technology gives your patients a healing experience beyond classic vacuum therapy. Why TopiVac Medium Clinic v4? Because TopiVac is not just a device; it represents a turning point in wound treatment. Our hybrid treatment technology combines Negative Pressure Wound Therapy (NPWT) with O2/O3 Gas Therapy, Electro TENS, and moistening methods. This combination accelerates wound healing while significantly reducing the risk of infection. World’s First Our hybrid treatment technology stands out as a first in the world. While our competitors cannot offer such a product, you can provide your patients with a unique healing process. Advanced Results We offer the possibility of more effective and lasting healing, far beyond the results provided by classic vacuum therapy. Comprehensive Approach A customizable treatment process tailored to meet individual patient needs. Learn more topivac.com/en e-mail: trade@amedus.com EPUAP - European Pressure Ulcer Advisory Panel EWMA • EWMA • European Wound Management Association Wound, Ostomy, and Continence Nurses Society™ (WOCN®) WUWHS 2026 American Professional Wound Care Association (APWCA)) DGfW #AdvancedWoundCare #WoundCare #NPWT #WoundDressing #OxygenTherapy #NegativePressureTherapy #DiabeticWounds #InnovativeWoundHealing #WoundManagement #PatientCare #MedicalDevices #HealthcareInnovation #SurgicalWounds

Newly released results from a 2023 survey of 5,254 U.S. acute care hospitals show there are many opportunities for improving hospital sepsis programs. To help optimize hospital sepsis programs and improve outcomes for the at least 1.7 million people in America affected by sepsis each year, CDC released the first-ever Hospital Sepsis Program Core Elements last year. This resource is designed to help U.S. hospitals implement, monitor, and optimize institutional sepsis programs and sepsis outcomes. Read the summary: https://bit.ly/46vb7b4

Experience the Healing Revolution with NPWT at BH Wound Care! At BH Wound Care, we're dedicated to pioneering wound care solutions, and we're excited to introduce the transformative Negative Pressure Wound Therapy (NPWT)! What is NPWT? NPWT is an FDA-approved therapy that utilizes negative pressure to accelerate wound healing by promoting tissue granulation, reducing edema, and enhancing blood flow. How NPWT Works: Our expert team at BH Wound Care employs NPWT to create a controlled environment that stimulates the wound healing process, aiding in the removal of excess fluids and promoting tissue regeneration. Conditions NPWT Treats: From chronic wounds to post-surgical incisions, NPWT is a versatile therapy used for a range of wound types. Clinical Effectiveness: NPWT has demonstrated significant efficacy in various clinical studies, leading to faster healing rates and improved patient outcomes. If you or a loved one is grappling with challenging wounds, contact BH Wound Care for a consultation. Experience the healing revolution with NPWT! #WoundCare #NPWT #HealingInnovation #BHHealthcare #BHWC

[AMS Trilogy Workshop by MPS Hospital & Clinical Pharmacy Chapter] Unlocking Optimal Doses: Enhancing Patient Outcomes with AMS! 💊 Join Mr. Adam Jaafar, esteemed pharmacist from Hospital Sungai Buloh, as he unveils the secrets of dose optimization in anti-infective therapies. 👨🔬 Mr. Jaafar will explore how tailoring doses to patient characteristics, causative organisms, infection sites, and pharmacokinetics can revolutionize patient outcomes. 🔍💫 💊 Discover the power of extended infusions, once-daily dosing, and specialized adjustments for unique populations. 💪 Don't miss this opportunity to elevate your AMS practice and transform patient care! ✨ Register now!!! at https://lnkd.in/g5fMW_Zq #AMSTrilogy #DoseOptimization #PatientOutcomes

Interstitial cystitis practitioners: please share the link to register for this FREE Masterclass with your IC patients! Introducing, the Roadmap To IC Relief Masterclass! This is a FREE live Masterclass that will teach you: 👉🏻The very common mistake you’re probably making in your day-to-day life and why it’s making you feel stuck with your IC 👉🏻The 3 main things holding you back from getting relief from IC (long-term relief, not just a short-term band-aid solution!) 👉🏻What changes you can implement NOW to set yourself up for long-term relief from your IC symptoms The FREE Masterclass will have 2 live sessions: Monday, February 6th at 7pm EST Tuesday, February 7th at 2pm EST After the class, you’ll... 🎉Have clarity on what is missing in your IC treatment regimen 🎉Feel confident that you can get relief from your IC symptoms in the near future 🎉Have a clear roadmap (with action steps) on what to do next on your IC journey Link to register: https://lnkd.in/e4YPJE4e

Excited for the September issue of the Journal of Cardiopulmonary Rehabilitation and Prevention? 🫀🫁🥳 Watch this video where Todd Brown, MD, MSPH, FACC, FAHA, MAACVPR, details what to expect in the fifth JCRP issue of 2024:

Clinical and Health Economics data at it’s finest! A win-win for Patients, Prescribers and Payers!

Empower your teams with enhanced diagnostic capabilities this respiratory season. As winter respiratory season approaches, it’s essential to equip your teams with the right tools for effective and efficient patient care. Transform operational efficiency and improve patient outcomes with Exdia TRF Plus high-performance respiratory portfolio: ✅COVID-19 ✅Flu A & B ✅Strep A —all on a single, fully connected, easy-to-use platform with built-in quality control. Additionally, we offer a standalone ✅ RSV test, 510(k) FDA cleared and CLIA-Waived, to complete our comprehensive respiratory portfolio. Ensure your team is prepared for the season ahead! Empowering Patients and Clinicians with Faster, Reliable Results The Exdia TRF Plus Platform is transforming clinical diagnostics with high-performance across multiple assays, providing crucial support to physicians, especially during the challenging winter months. By delivering rapid results where they’re needed most, clinicians can triage patients with respiratory symptoms more efficiently. Discover how the Exdia TRF Plus Platform stands out from other solutions in a comprehensive validation study from Switzerland. Lear more here: https://lnkd.in/dDmwXWj3

A new NHS Supply Chain case study shows how a 12-month trial of using our Leukomed Sorbact wound dressing after caesarean sections instead of cheaper, standard dressings not only achieved significant reductions in surgical site infections, hospital admissions and the use of antibiotics, but also delivered significant cost savings for the NHS too. This is Value-Based Procurement and it is a win-win-win for patients, the NHS, and healthcare professionals. Read the full case study here - https://bit.ly/4dDIM4V